AGL 2043
AGL 2043 is a reversible and ATP-competitive small molecule inhibitor targeting type III receptor tyrosine kinases. It is utilized in biochemical and cellular assays to investigate kinase signaling pathways in oncology and cardiovascular research, as evidenced by its application in published in vitro studies.
Product Specifications
CAS Number
226717-28-8
Field of Research
Cancer Biology, Cardiovascular Research, Signal Transduction
Smiles
CN1C=2C (=CC=3C (C2) =NC=C (N3) C4=CC=CS4) N=C1C
Molecular Formula
C15H12N4S
Molecular Weight
280.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2086-66W-Biotin 100 µL
Caspase 1, CT (Caspase 1 Apoptosis-related Cysteine Peptidase, Caspase 1 Apoptosis-related Cysteine Protease, Caspase-1, CASP 1, CASP1, CASP-1, Interleukin 1 beta Convertase, IL1B Convertase, IL-1BC, IL1BC, Interleukin 1 beta Convertase Precursor, Interleukin 1 beta Converting Enzyme, Interleukin 1B Converting Enzyme, IL-1 beta-converting Enzyme, ICE, IL1BCE, P45) (Biotin)
Sign In for Pricing
View Details MBS6449993-01 0.1 mL
TRAF2 (TNF Receptor-associated Factor 2, TRAF 2, ITRAF, I-TRAF) (FITC)
Sign In for Pricing
View Details MBS6449993-02 5x 0.1 mL
TRAF2 (TNF Receptor-associated Factor 2, TRAF 2, ITRAF, I-TRAF) (FITC)
Sign In for Pricing
View Details 
GTR15265675 1 Vial
Lentiviral mouse Tnfrsf13c shRNA (UAS) - Lentiviral mouse Tnfrsf13c shRNA (UAS) plasmid
Sign In for Pricing
View Details